|The HPV11 E7 n/a (Catalog #MBS833171) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s HPV11 E7 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunoassays.
MBS833171 can be used in a sandwich immunoassay as a coating antibody in conjunction with MBS834987 as the conjugate antibody. Researchers should empirically determine the suitability of the HPV11 E7 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal HPV11 antibody.
Biological Significance: Infection with specific types of human Papillomavirus (HPV) has been associated with an increased risk of developing cervical neoplasia. HPV types 6 and 11 have been associated with relatively benign diseases such as genital warts but types 16 and 18 are the causative agents of cervical, vaginal and vulvar malignancies. Biohazard Information: This product is sold as an antibody preparation for research use only. Standard Laboratory Practices should be followed when handling this material. Contains sodium azide (0.1 %) as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Immunogen: Human Papilloma Virus Type 11 antibody was raised in mouse using HPV oncoprotein E7, Type 11 as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing HPV11 E7 are readily searchable from our website. Different antibodies against the same target such as HPV11 E7 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.